SCHEMBL18307362

SCHEMBL18307362

C[C@@H]1CNCC[C@H]1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 1/20 0.43
GABRA5 P31644 3/20 0.43
GABRB2 P47870 3/20 0.43
TSHR P16473 2/20 0.43
GABRA1 P14867 2/20 0.43
GABRA4 P48169 2/20 0.43
GABRP O00591 1/20 0.43
GABRD O14764 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRE P78334 1/20 0.43
PMP22 Q01453 1/20 0.43
GABRA6 Q16445 1/20 0.43
GABRG1 Q8N1C3 1/20 0.43
GABRG3 Q99928 1/20 0.43
GABRQ Q9UN88 1/20 0.43
SLC6A1 P30531 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13439403 1.00 SLC1A2 (0.43) SLC1A2GABRA5GABRB2TSHRGABRA1
SCHEMBL4001723 1.00 SLC1A2 (0.43) SLC1A2GABRA5GABRB2TSHRGABRA1
SCHEMBL4009207 1.00 SLC1A2 (0.43) SLC1A2GABRA5GABRB2TSHRGABRA1
SCHEMBL2312750 1.00 SLC1A2 (0.43) SLC1A2GABRA5GABRB2TSHRGABRA1
SCHEMBL22863934 1.00 SLC1A2 (0.43) SLC1A2GABRA5GABRB2TSHRGABRA1
SCHEMBL3027763 1.00 SLC1A2 (0.43) SLC1A2GABRA5GABRB2TSHRGABRA1
Hydrochloric Acid SCHEMBL2158140 0.98 SLC1A2 (0.42) SLC1A2GABRA5GABRB2TSHRGABRA1
Hydrochloric Acid SCHEMBL2158135 0.98 SLC1A2 (0.42) SLC1A2GABRA5GABRB2TSHRGABRA1
Hydrochloric Acid SCHEMBL2158131 0.98 SLC1A2 (0.42) SLC1A2GABRA5GABRB2TSHRGABRA1
SCHEMBL16584219 0.83 GABRA5 (0.43) SLC1A2GABRA5GABRB2TSHRGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712961-A2 KRAS G12S AND G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2026-03-25 EP disclosed
WO-2024238633-A2 KRAS G12S AND G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2024-11-21 WO disclosed
WO-2016200851-A1 NUCLEAR RECEPTOR MODULATORS ABBVIE INC. (US) 2016-12-15 WO disclosed